0090-9556/04/3207-707-714$20.00
DMD 32:707-714, 2004
INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR
IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER
Takashi Ashino,
Takiko Oguro,
Seiji Shioda,
Reiko Horai,
Masahide Asano,
Kenji Sekikawa,
Yoichiro Iwakura,
Satoshi Numazawa, and
Takemi Yoshida
Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan (T.A., S.N., T.Y); Japan Development, R&D Alcon Research, Ltd., Fort Worth, Texas (T.O.); Department of Anatomy, School of Medicine, Showa University, Tokyo, Japan (S.S.); Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan (R.H., Y.I.); Department of Transgenic Animal Science, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan (M.A.); and Department of Molecular Biology and Immunology, National Institute of Agrobiological Sciences, Ibaraki, Japan (K.S.)
Bacillus Calmette-Guérin (BCG) and lipopolysaccharide (LPS) are well known potent activators of the cell-mediated immune system and thus lead to the decreases in cytochrome P450 (P450). In this study we used interleukin (IL)-1
/ß, IL-6, or tumor necrosis factor
(TNF
) knockout (KO) mice to investigate how each cytokine is involved in P450 down-regulation, especially CYP3A11 and 2C29. BCG (40 mg/kg) was found to reduce both CYP3A11 and 2C29 mRNAs at 24 h after treatment in IL-1
/ß KO mice in a manner similar to that seen in wild-type mice. CYP3A11 mRNA, but not CYP2C29 mRNA, was significantly decreased by BCG treatment in the TNF
KO mice, although the decrease was less than that of wild-type or IL-1
/ß KO mice. In contrast, BCG showed no significant effect on CYP3A11 and 2C29 mRNAs in IL-6 KO mice. On the other hand, LPS was able to decrease CYP3A11 and 2C29 mRNA levels in all of the cytokine KO mice and markedly increased systemic levels of TNF
; BCG (40 mg/kg) lacked such activity. The present study has shown that IL-6 and TNF
are likely to be major factors involved in the down-regulation of CYP3A11 and 2C29 mRNAs in mice. In addition, there exist differences in the amount and/or kind of cytokines released by BCG or LPS, the latter being more potent than the former. This will be a possible reason for differential capability of P450 down-regulation between BCG and LPS.
Address correspondence to: Takemi Yoshida, Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555. E-mail: yoshida{at}pharm.showa-u.ac.jp
This article has been cited by other articles:

|
 |

|
 |
 
A. E. Aitken and E. T. Morgan
Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes
Drug Metab. Dispos.,
September 1, 2007;
35(9):
1687 - 1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lee, J. R. Hutson, V. K.-F. Tzau, and D. S. Riddick
Regulation of Constitutive Mouse Hepatic Cytochromes P450 and Growth Hormone Signaling Components by 3-Methylcholanthrene
Drug Metab. Dispos.,
September 1, 2006;
34(9):
1530 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Richardson and E. T. Morgan
Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice
J. Pharmacol. Exp. Ther.,
August 1, 2005;
314(2):
703 - 709.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.